Conference Reports

Tenecteplase Thrombolysis in Acute Stroke Associated With Lower Rates of Intracranial Bleeding vs Alteplase

By Nancy Melville

VIRTUAL -- February 10, 2022 -- Patients treated with tenecteplase for acute ischaemic stroke showed significantly lower rates of symptomatic intracranial haemorrhage compared with treatment with alteplase, according to a study presented at the 2022...

Delayed Post-Traumatic Intracranial Haemorrhage in Patients on Anticoagulant/Antiplatelet Medications

By Alex Morrisson

VIRTUAL -- December 2, 2021 -- A small percentage of patients on anticoagulation therapy who presented to the emergency department after experiencing head trauma and had an initial negative imaging study subsequently developed a brain haemorrhage, according to a study...

Low-Dose Nebulised Ketamine Offers Comparable Pain Control as Higher Doses in Emergency Department Setting

By Louise Gagnon

VIRTUAL -- November 3, 2021 -- Results of a randomised trial presented at the 2021 Annual Meeting of the American College of Emergency Physicians (ACEP) suggest that of 3 possible doses of nebulised...

Abnormal Blood Glucose Levels in Febrile Children Not Associated With Bacterial Infection

By Louise Gagnon

VIRTUAL -- November 3, 2021 -- Abnormal blood glucose levels in young children presenting to the emergency department with fever was not indicative of a serious bacterial infection, according to a study presented at the 2021 Annual Meeting of the American College of...

STRAUMA Expedites Assessment of Stroke, Trauma to Facilitate Timely Administration of Lifesaving Interventions

By Erin Burns, PhD

VIRTUAL -- October 28, 2021 -- STRAUMA, a novel alert, allows for the expedited assessment of stroke and trauma, facilitating the timely administration of lifesaving interventions, according to a study presented at the 2021 American College of Surgeons (ACS) Clinical...

Remdesivir Prevents COVID-19-Related Hospitalisation, Death in High-Risk Patients

By Brian Hoyle

VIRTUAL -- October 4, 2021 -- A 3-day course of intravenous remdesivir was safe, well tolerated, and highly effective at preventing coronavirus disease 2019 (COVID-19) related hospitalisation or death in high-risk non-hospitalised individuals, according to a study presented...

Long-Acting Antibody Combination Prevents Symptomatic COVID-19

By Brian Hoyle

VIRTUAL -- October 2, 2021 -- Primary efficacy analysis of the phase 3 PROVENT has demonstrated the effectiveness of the prophylactic administration of AZD7442, a long-acting antibody combination of tixagevimab and cilgavimab, in significantly lessening the development of...

New Onset of Graves’ Disease After COVID-19 Infection

By Erika Powers

VIRTUAL -- October 1, 2021 -- At the Virtual 2021 Annual Meeting of the American Thyroid Association (ATA), physicians presented a case series of patients who developed new onset Graves’ disease after infection with coronavirus disease 2019 (COVID-19).

“All 3 of our...

Clinical Frailty Is Associated With Increased In-Hospital, Mortality in Patients With COVID-19

By Nancy Melville

BRUSSELS -- September 7, 2021 -- Patients with coronavirus disease 2019 (COVID-19) who have high scores indicating clinical frailty show significantly higher rates of in-hospital and 30-day mortality, according to a study presented at the 40th International Symposium on...

Intravenous Immunoglobulins Decrease the Incidence of Bacterial Secondary Infections in Patients With Severe COVID-19

By Nancy Melville

BRUSSELS -- September 7, 2021 -- The addition of intravenous (IV) immunoglobulin therapy to antibiotics significantly prevented secondary infections and mortality among patients with severe coronavirus disease 2019 (COVID-19) who required mechanical ventilation,...